- Home
- HCI vs TVTX Comparison
HCI vs TVTX Comparison
Compare HCI & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- TVTX
- Stock Information
- Founded
- HCI 2006
- TVTX 2008
- Country
- HCI United States
- TVTX United States
- Employees
- HCI N/A
- TVTX N/A
- Industry
- HCI Property-Casualty Insurers
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- HCI Finance
- TVTX Health Care
- Exchange
- HCI Nasdaq
- TVTX Nasdaq
- Market Cap
- HCI 1.9B
- TVTX 1.7B
- IPO Year
- HCI N/A
- TVTX N/A
- Fundamental
- Price
- HCI $168.69
- TVTX $15.02
- Analyst Decision
- HCI Strong Buy
- TVTX Strong Buy
- Analyst Count
- HCI 4
- TVTX 14
- Target Price
- HCI $181.25
- TVTX $33.31
- AVG Volume (30 Days)
- HCI 118.6K
- TVTX 1.9M
- Earning Date
- HCI 05-08-2025
- TVTX 05-01-2025
- Dividend Yield
- HCI 0.95%
- TVTX N/A
- EPS Growth
- HCI 4.05
- TVTX N/A
- EPS
- HCI 10.46
- TVTX N/A
- Revenue
- HCI $759,870,000.00
- TVTX $273,533,000.00
- Revenue This Year
- HCI $19.21
- TVTX $74.41
- Revenue Next Year
- HCI $2.29
- TVTX $48.90
- P/E Ratio
- HCI $16.13
- TVTX N/A
- Revenue Growth
- HCI 20.95
- TVTX 75.65
- 52 Week Low
- HCI $83.65
- TVTX $6.79
- 52 Week High
- HCI $176.40
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- HCI 67.12
- TVTX 35.45
- Support Level
- HCI $161.01
- TVTX $16.37
- Resistance Level
- HCI $166.27
- TVTX $15.48
- Average True Range (ATR)
- HCI 5.10
- TVTX 1.00
- MACD
- HCI -0.33
- TVTX -0.51
- Stochastic Oscillator
- HCI 87.58
- TVTX 3.83
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.